Business
Biophytis S A : obtains EMA authorization to launch its Phase 2 clinical trial in obesity
Biophytis S A : obtains EMA authorization to launch its Phase 2 clinical trial in
About this update from Biophytis Sa
03 Sep 2025 07:00 CEST Subscribe Issuer BIOPHYTIS See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo 16165_1355837_Approval_EMA_Biophytis_Phase_2_OBA_Sept_2025_VENG.pdf Source Biophytis Provider Les Echos Company Name BIOPHYTIS ISIN FR001400OLP5 Symbol ALBPS Market Euronext Growth